Morningstar Investment Services LLC Halozyme Therapeutics, Inc. Transaction History

Morningstar Investment Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$37.35 - $48.3 $187,198 - $242,079	-5,012 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$31.97 - $41.06 $607 - $780	-19 Reduced 0.38%	5,012 $202,000
Q4 2021 Feb 01, 2022	BUY	$31.82 - $40.75 $160,086 - $205,013	5,031 New	5,031 $202,000
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $192,350 - $232,100	-5,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$25.81 - $43.62 $129,050 - $218,100	5,000 New	5,000 $214,000
Q1 2020 May 04, 2020	SELL	$13.9 - $21.83 $139,000 - $218,299	-10,000 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$11.76 - $17.4 $117,600 - $174,000	10,000	10,000 $174,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.68B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Morningstar Investment Services LLC, based on Form 13F filings with the SEC.

Stay updated on Morningstar Investment Services LLC with notifications on news.